Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®).
Lee MK, Mitchell SA, Basch E, Mazza GL, Langlais BT, Thanarajasingam G, Ginos BF, Rogak L, Meek EA, Jansen J, Deal AM, Carr P, Blinder VS, Jonsson M, Mody GN, Mendoza TR, Bennett AV, Schrag D, Dueck AC. Lee MK, et al. Among authors: mendoza tr. Qual Life Res. 2024 Nov 6. doi: 10.1007/s11136-024-03819-5. Online ahead of print. Qual Life Res. 2024. PMID: 39503942
Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) in a diverse cancer sample.
Mead-Harvey C, Basch E, Rogak LJ, Langlais BT, Thanarajasingam G, Ginos BF, Lee MK, Yee C, Mitchell SA, Minasian LM, Mendoza TR, Bennett AV, Schrag D, Dueck AC, Mazza GL. Mead-Harvey C, et al. Among authors: mendoza tr. Clin Trials. 2024 Oct 23:17407745241286065. doi: 10.1177/17407745241286065. Online ahead of print. Clin Trials. 2024. PMID: 39440720 Free article.
Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma.
Cleeland CS, Keating KN, Cuffel B, Elbi C, Siegel JM, Gerlinger C, Symonds T, Sloan JA, Dueck AC, Bottomley A, Wang XS, Williams LA, Mendoza TR. Cleeland CS, et al. Among authors: mendoza tr. Sci Rep. 2024 Jun 27;14(1):14839. doi: 10.1038/s41598-024-62307-5. Sci Rep. 2024. PMID: 38937473 Free PMC article. Clinical Trial.
Clinical Aspects and Etiologic Investigation of Pediatric Patients With Acute Liver Failure.
Luglio M, Marques TCS, Pereira MFB, Delgado AF, de Carvalho WB, Tannuri ACA, Sandy NS, Litvinov N, de Paula CSY, Dos Santos AG, Lazari CDS, Gouvea MSG, de Paula AV, Mendoza TRT, Tanigawa RY, Lima FR, Hirayama AB, Dos Santos IGG, Pinho JRR, Sabino EC, Mendes-Correah MC, Alves VAF, Marques HHS. Luglio M, et al. Among authors: mendoza trt. Transplant Proc. 2023 Nov;55(9):2121-2125. doi: 10.1016/j.transproceed.2023.08.004. Epub 2023 Sep 26. Transplant Proc. 2023. PMID: 37758563
Encephalopathy Caused by Human Parvovirus B19 Genotype 1 Associated with Haemophilus influenzae Meningitis in a Newborn.
Ferreira NE, da Costa AC, Kallas EG, Silveira CGT, de Oliveira ACS, Honorato L, Paião HGO, Lima SH, de M Vasconcelos D, Côrtes MF, Costa SF, Mendoza TRT, Gomes HR, Witkin SS, Mendes-Correa MC. Ferreira NE, et al. Among authors: mendoza trt. Curr Issues Mol Biol. 2023 Aug 22;45(9):6958-6966. doi: 10.3390/cimb45090439. Curr Issues Mol Biol. 2023. PMID: 37754223 Free PMC article.
Pilot study of a Spanish language measure of financial toxicity in underserved Hispanic cancer patients with low English proficiency.
Shi JJ, McGinnis GJ, Peterson SK, Taku N, Chen YS, Yu RK, Wu CF, Mendoza TR, Shete SS, Ma H, Volk RJ, Giordano SH, Shih YT, Nguyen DK, Kaiser KW, Smith GL. Shi JJ, et al. Among authors: mendoza tr. Front Psychol. 2023 Jul 10;14:1188783. doi: 10.3389/fpsyg.2023.1188783. eCollection 2023. Front Psychol. 2023. PMID: 37492449 Free PMC article.
Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID).
Williams LA, Whisenant MS, Mendoza TR, Peek AE, Malveaux D, Griffin DK, Ponce DA, Granwehr BP, Sheshadri A, Hutcheson KA, Ali SM, Peterson SK, Heymach JV, Cleeland CS, Subbiah IM. Williams LA, et al. Among authors: mendoza tr. J Patient Rep Outcomes. 2023 May 26;7(1):48. doi: 10.1186/s41687-023-00591-x. J Patient Rep Outcomes. 2023. PMID: 37237077 Free PMC article.
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience.
Altan M, Soto F, Zhong LL, Akhmedzhanov FO, Wilson NR, Zarifa A, Albittar AA, Yang V, Lewis J, Rinsurongkawong W, Jack Lee J, Rinsurongkawong V, Zhang J, Gibbons DL, Vaporciyan AA, Jennings K, Khawaja F, Faiz SA, Shannon VR, Shroff G, Godoy MCB, Daver NG, Gandhi S, Mendoza TR, Naing A, Daniel-MacDougall C, Heymach JV, Sheshadri A. Altan M, et al. Among authors: mendoza tr. Oncologist. 2023 Nov 2;28(11):e1065-e1074. doi: 10.1093/oncolo/oyad118. Oncologist. 2023. PMID: 37156009 Free PMC article.
Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period.
Lee MK, Basch E, Mitchell SA, Minasian LM, Langlais BT, Thanarajasingam G, Ginos BF, Rogak LJ, Mendoza TR, Bennett AV, Schrag D, Mazza GL, Dueck AC. Lee MK, et al. Among authors: mendoza tr. Qual Life Res. 2023 Jul;32(7):2047-2058. doi: 10.1007/s11136-023-03374-5. Epub 2023 Mar 10. Qual Life Res. 2023. PMID: 36897529 Free PMC article.
181 results